The direct immunofluorescence (IF) test for rabies is a diagnostic procedure performed in laboratories throughout the world. In the United States, for example, approximately 90,000 specimens are examined annually (4) . The direct IF test is the most rapid and reliable method of diagnosing rabies (14) and is often crucial in determining the need for antirabies treatment in human beings exposed to the disease, yet the test itself presents some hazard to the laboratory worker. Infectious rabies virus is used to adsorb antibody in the diagnostic antirabies conjugate to confirm the specificity of observed fluorescence. There is no commercial supplier for this control reagent in the United States.
Additionally, although fluorescein isothiocyanate (FITC)-conjugated antirabies serum is commercially available in the United States, large amounts of rabies virus are needed to produce it.
One alternative to using reagents produced with infectious rabies virus is to develop a noninfectious rabies virus protein that has functional characteristics identical to or closely resembling those of the native species.
We now report the development of cell-culture-derived rabies diagnostic reagents by recombinant DNA technology using the baculovirus expression vector system. This system exploits the strong polyhedrin promoter region of the baculovirus genome (13) and is used to produce viral antigens in abundant quantities for in vitro studies (3, 5, 6, 9) . In this report, we describe the production of large amounts of baculovirus-expressed rabies virus N protein and the successful use of the protein as a rabies virus-free source of diagnostic reagents. Wild-type baculovirus Autographa californica nuclear polyhedrosis virus (AcNPV), E-2 strain, and the plasmid transfer vector pAcYMI were provided by D. H. L. Bishop, Natural Environment Research Council Institute of Virology, Oxford, England. The recombinant plasmid was constructed in our laboratory from the CVS strain of rabies virus (unpublished data) and cotransfected with AcNPV DNA into Sf9 cells. The transfected cells were incubated for 6 days at 28°C. Cells were then lysed, blotted onto nitrocellulose paper, and hybridized as reported elsewhere (13). N gene recombinants were detected with 32P-labeled, nick-translated rabies virus N gene sequences by using a nick translation kit (Bethesda Research Laboratories, Inc., Gaithersburg, Md.). Three rounds of limiting-dilution dot hybridization purification (13) produced recombinant viruses devoid of wild-type baculovirus. One recombinant virus, B7, was selected because it had a high titer, and it was later used to infect Sf9 cells for further study and to produce virus stocks.
MATERIALS AND METHODS
Rabies virus-infected mouse brain (RMB) and normal mouse brain (NMB) adsorbing suspensions were prepared in our laboratory by techniques described elsewhere (14 Similar experiments were performed with rabies virusinfected and uninfected brain impressions. Field strains of rabies virus were obtained from diagnostic specimens submitted to CDC or to individual state public health laboratories. Touch impressions were made of the brain material submitted. Rabies virus-infected mouse brain impression slides were prepared from mice inoculated intracerebrally with field strains of rabies virus. NMB impressions were made from uninfected mice. All brain impression slides were acetone fixed for 4 h at -20°C and stored at -20°C.
Also, B7-infected cell cultures were tested by indirect IF with 16 monoclonal antibodies directed to different antigenic sites of the N protein of rabies virus (12) . The monolayers were allowed to react with the monoclonal antibodies for 30 min at 37°C, washed to remove unreacted antibody, and restained for 30 min at 37°C with FITC-labeled goat antimouse immunoglobulin G, heavy and light chain specific (Organon Teknika Corp., West Chester, Pa.).
Immune serum reagents. Five-week-old outbred Institute of Cancer mice (CDC, Atlanta, Ga.) were inoculated intraperitoneally with 0.5 ml of crude cell lysates from B7-infected, AcNPV-infected, or uninfected Sf9 cells. All cell suspensions were made in 0.01 M phosphate-buffered saline (pH 7.2) and subjected to three freeze-thaw cycles to lyse the cells, and total protein concentrations were standardized to 100 ,ug/ml prior to inoculation. Mice were bled 1 
RESULTS

Expression of rabies virus N protein in S. frugiperda cells.
Two recombinant baculoviruses containing the rabies virus N gene (A7 and B7) were identified and examined for their ability to produce rabies virus N protein in S. frugiperda cells. Cell lysates were resolved by SDS-PAGE (11% acrylamide). As controls, uninfected Sf9 cell lysates and wildtype AcNPV-infected cell lysates were analyzed similarly. Cells infected by A7 (Fig. 1, lane 4) and B7 (Fig. 1, lane 3) synthesized large amounts of a novel protein of the same molecular weight (55,000) as the rabies virus N protein. This protein was not synthesized in the uninfected Sf9 cells (Fig.  1, lane 1) or by AcNPV-infected cells (Fig. 1, lane 2 29,000-molecular-weight polyhedrin protein produced by AcNPV. Densitometric scanning of lane 3 ( Fig. 1, B7 (Fig. 2d) . The reactivity of antiserum from the B7-immune mice was adsorbed with RMB (Fig. 2e) in the recombinant virus-precipitated lanes (Fig. 3, lanes 3  and 6) .
We next performed a series of experiments to test the ability of B7-derived N protein to substitute for authentic rabies virus as a specificity control reagent. The three antirabies diagnostic reagents were preadsorbed with NMB, RMB, or B7-infected Sf9 cells. The specific reactivities of all three reagents were adsorbed equally well by RMB; for two of the reagents-HSR2 and the monoclonal antibody conju- gate-B7-infected cells also removed specific activity. The specific reactivity of HSR1, however, was only partially inhibited by B7-infected cells (Fig. 4) . Increasing the number of cells used as adsorbent, and thus the amount of N protein, did not further reduce the specific staining.
These observations were investigated further by immune precipitation experiments. 35S-labeled rabies virus was reacted with the three antirabies diagnostic reagents, which had been preadsorbed with Sf9 cells, B7-infected cells, RMB, or NMB (Fig. 5) In our studies, one of the HSR contained antibody populations reactive with both the N and the NS proteins.
Although this NS protein staining was not seen in every rabies virus-suspect brain examined, failure of a specificity control to adsorb this activity could complicate the diagnostic test. Thus, N protein alone is not a sufficient control for the specificity of all hyperimmune serum reagents. The recombinant-virus-expressed N protein is an excellent specificity control for the monoclonal reagent, however, and was fully equivalent to RMB in its ability to adsorb specific activity from this product.
Although both HSR were produced from animals inoculated with whole rabies virions, only HSR1 precipitated the NS protein of rabies virus. However, HSR1 is approximately 70 times more concentrated than HSR1, and although both were used at their optimal working dilutions, we suspect that the amount of NS antibody in HSR2 is insufficient to precipitate NS protein. Interestingly, neither HSR precipitated the rabies Gi, G2, or M protein.
The baculovirus expression vector system is easy to perform. S. frugiperda cells grow optimally at 28°C but can survive at temperatures between 22 and 30°C. They do not require C02 during incubation. Additionally, virus stocks harvested from infected cells can be stored at 4°C for more than 2 years with little change in titer (13).
We are currently collaborating with several state health departments to test baculovirus-produced rabies virus N protein as an alternative source of rabies virus adsorbing suspension and are continuing to test the applicability of hyperimmune serum to N protein as a diagnostic reagent.
The baculovirus expression vector system offers new possibilities for the development of safer, less expensive, and more stable reagents.
